New Lion CFO Will Begin on April 1 | GenomeWeb

NEW YORK, March 18 - Lion Bioscience on Monday said it has hired Martin Hollenhorst as chief financial officer to replace Klaus Sprockamp, who perished in the Sept. 11 attacks on the World Trade Center here.

Hollenhorst, 43, will "assume overall responsibility for the finance, controlling, and accounting divisions" of Lion as of April 1, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.

Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.

Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.

A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.